Latest total revenue for MRM: $8.9B, below the Consumer Discretionary sector average of $1.6T.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
MEDIROM Healthcare Technologies posts a total revenue of $8.9B as of December 2025. That compares with $100M in the prior-year period — up 8715.0% year over year. That is below the Consumer Discretionary sector average of $1.6T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, MEDIROM Healthcare Technologies's total revenue was $100M. The latest reading is $8.9B — a 8715.0% year-over-year increase (period ending December 2025). Use the history and growth charts on this page for a longer lookback.
For Consumer Discretionary stocks, a total revenue near $1.6T is typical. MEDIROM Healthcare Technologies's $8.9B is lower that level. That is roughly 99.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Total Revenue is one piece of MEDIROM Healthcare Technologies's financial statement story. At $8.9B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for MRM's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $1.6T), and (3) consistency with growth and profitability. This page covers the first two; MEDIROM Healthcare Technologies's other metric pages and overview cover the third.